Advanced Search >

Risk Minimisation Materials

Direct Communication to Non-HCPs, Wholesalers and purchasing groups. Prenoxad 0.91 mg/ml. Correction made to the Prenoxad Injection labelling.

Direct Communication to Non-medical practitioners involved in treatment services, Wholesalers and other direct purchasing groups on the correction made to the Prenoxad Injection following a historic error in the drug product labelling. Naloxone Hydrochloride, Prenoxad Injection, label correction

For Healthcare Professionals

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue